ZyVersa Therapeutics, Inc.
ZVSA· OTC
ZVSAZyVersa Therapeutics, Inc.
Filed May 15, 2024 · 10-Q · 45 days after period end · 0001493152-24-019517
| Metric | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|
| Net Income | -$2.83M | -$3.54M | -$720.01K |
| EPS Diluted | -$4.53 | -$135.88 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ZyVersa Therapeutics, Inc. · CIK 1859007 · Engraved from SEC EDGAR
ended Mar 31, 2024 · filed May 15, 2024 · 45 d after period end
